Agnes Kenengton Anjana

Agnes Kenengton Anjana

Active Director Director DIN 08133041
DIN 08133041 First appointment May 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value •••• Premium profile

About Agnes Kenengton Anjana

Data last updated:

Agnes Kenengton Anjana is a Director at Helken Pharma Private Limited (since 2018). The company operates in Healthcare. Helken Pharma Private Limited reported revenue of ₹24,624 (FY 2024).

DIN 08133041
Primary Designation Director
Industry Healthcare
First Appointment 14 May 2018
Oldest Company Age 8 yrs
Largest company Helken Pharma Private Limited · ₹24,624 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Helken Pharma Private Limited U74999TN2018PTC122666
Director14 May 20182018₹24,624 (FY 2024)Active

Board colleagues of Agnes Kenengton Anjana

NameDINCompanyDesignation
Augustine Helen08133039Helken Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Helken Pharma Private Limited
Premium access

Shareholding and investment profile for Agnes Kenengton Anjana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Agnes Kenengton Anjana

Agnes Kenengton Anjana currently holds 1 directorship: Helken Pharma Private Limited (Director, since 14 May 2018, revenue ₹24,624 (FY 2024)).

Agnes Kenengton Anjana was first appointed on 14 May 2018 as Director at Helken Pharma Private Limited.

The current boards of Agnes Kenengton Anjana's companies include Augustine Helen (Helken Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available